Torrance, CALIFORNIA2 Active Studies

Myeloproliferative Neoplasms Clinical Trials in Torrance, CALIFORNIA

Find 2 actively recruiting myeloproliferative neoplasms clinical trials in Torrance, CALIFORNIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
900
Enrolling

Recruiting Myeloproliferative Neoplasms Studies in Torrance

About Myeloproliferative Neoplasms Clinical Trials in Torrance

Myeloproliferative neoplasms (MPNs) are blood cancers in which the bone marrow overproduces red blood cells, platelets, or white blood cells. Types include polycythemia vera, essential thrombocythemia, and myelofibrosis. Treatment depends on the specific type and risk factors.

There are currently 2 myeloproliferative neoplasms clinical trials recruiting participants in Torrance, CALIFORNIA. These studies are seeking a combined 900 participants. Research is being sponsored by Kartos Therapeutics, Inc., Merck Sharp & Dohme LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.

Myeloproliferative Neoplasms Clinical Trials in Torrance — FAQ

Are there myeloproliferative neoplasms clinical trials in Torrance?

Yes, there are 2 myeloproliferative neoplasms clinical trials currently recruiting in Torrance, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Torrance?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Torrance research site will contact you about next steps.

Are clinical trials in Torrance free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Torrance studies also compensate for your time and travel.

What myeloproliferative neoplasms treatments are being tested?

The 2 active trials in Torrance are testing new therapies including novel drugs, biologics, and treatment approaches for myeloproliferative neoplasms.

Data updated March 2, 2026 from ClinicalTrials.gov